BEST UNLIMITED TURBO LONG CERTIFICATE - ROCHE GS Stock

Certificat

S34738

DE000SW77C24

Market Closed - Borsa Italiana 01:43:50 2024-07-17 pm EDT
7.54 EUR +28.67% Intraday chart for BEST UNLIMITED TURBO LONG CERTIFICATE - ROCHE GS
Current month+49.50%
1 month+59.44%

Comparison chart between the derivative product and it's underlying value

End-of-day quotes
Date Price Change
24-07-17 7.54 +28.67%
24-07-16 5.86 +2.27%
24-07-15 5.73 +8.52%
24-07-12 5.28 +4.35%
24-07-11 5.06 +5.42%

Real-time Borsa Italiana

Last update July 17, 2024 at 01:43 pm EDT

More quotes

Static data

Product typeKnock-Out without Stop Loss
Buy / SellCALL
Underlying ROCHE HOLDING AG
IssuerLogo Issuer Société Générale Société Générale
S34738
ISINDE000SW77C24
Date issued 2024-03-27
Strike 204 CHF
Maturity Unlimited
Parity 10 : 1
Emission price-
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 7.61
Lowest since issue 1.316
Spread 0.28
Spread %3.65%

Company Profile

Roche Holding AG (Roche) is a research-based healthcare company. The Company's operating businesses are organized into two divisions: Pharmaceuticals and Diagnostics. The Pharmaceuticals Division consists of two business segments: Roche Pharmaceuticals and Chugai. The Diagnostics Division consists of four business areas: Diabetes Care, Molecular Diagnostics, Professional Diagnostics and Tissue Diagnostics. The Company develops medicines for various disease areas, including oncology, immunology, infectious diseases, ophthalmology and neuroscience. Its pharmaceutical products include Anaprox, Avastin, Bactrim, Bondronat, CellCept, Cotellic, Dilatrend, Dormicum, Invirase, Kadcyla, Kytril (Kevatril), Lariam, MabThera, Madopar, Neupogen, Pegasys, Perjeta, Pulmozyme, Rocaltrol, Rocephin and Roferon-A. The Company offers products for researchers, including cell analysis, gene expression, genome sequencing and nucleic acid purification.
Sector
-
More about the company

Ratings for Roche Holding AG

Trading Rating
Investor Rating
ESG Refinitiv
A+
More Ratings

Consensus: Roche Holding AG

Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
20
Last Close Price
258.9 CHF
Average target price
274 CHF
Spread / Average Target
+5.83%
Consensus
  1. Stock Market
  2. Certificates
  3. S34738 Certificat